A detailed history of E. Ohman J:Or Asset Management Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 445,709 shares of MRK stock, worth $43 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
445,709
Previous 372,004 19.81%
Holding current value
$43 Million
Previous $46.1 Billion 9.9%
% of portfolio
1.25%
Previous 1.14%

Shares

55 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$111.15 - $128.97 $8.19 Million - $9.51 Million
73,705 Added 19.81%
445,709 $50.6 Billion
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $5.8 Million - $6.23 Million
46,822 Added 14.4%
372,004 $46.1 Billion
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $259,093 - $301,901
2,288 Added 0.71%
325,182 $42.9 Billion
Q4 2023

Feb 15, 2024

SELL
$100.18 - $109.02 $18.7 Million - $20.3 Million
-186,213 Reduced 36.58%
322,894 $35.2 Billion
Q3 2023

Feb 06, 2024

BUY
$102.95 - $114.33 $52.4 Million - $58.2 Million
509,107 New
509,107 $52.4 Billion
Q2 2023

Apr 05, 2024

BUY
$108.61 - $118.38 $137,283 - $149,632
1,264 Added 0.22%
581,927 $67.1 Billion
Q1 2023

Apr 05, 2024

BUY
$102.94 - $114.86 $3.48 Million - $3.88 Million
33,779 Added 6.18%
580,663 $61.8 Billion
Q4 2022

Apr 05, 2024

SELL
$87.44 - $112.11 $8.12 Million - $10.4 Million
-92,850 Reduced 14.51%
546,884 $60.7 Billion
Q3 2022

Apr 05, 2024

BUY
$84.53 - $94.96 $6.3 Million - $7.07 Million
74,499 Added 13.18%
639,734 $55.1 Billion
Q2 2022

Apr 05, 2024

SELL
$83.49 - $94.64 $9.42 Million - $10.7 Million
-112,803 Reduced 16.64%
565,235 $51.5 Billion
Q1 2022

Apr 05, 2024

BUY
$73.51 - $82.4 $1.74 Million - $1.95 Million
23,642 Added 3.61%
678,038 $55.6 Billion
Q4 2021

Apr 05, 2024

SELL
$72.28 - $90.54 $3.68 Million - $4.61 Million
-50,932 Reduced 7.22%
654,396 $50.2 Billion
Q3 2021

Apr 05, 2024

BUY
$71.68 - $78.83 $2.64 Million - $2.9 Million
36,810 Added 5.51%
705,328 $53 Billion
Q2 2021

Apr 05, 2024

BUY
$70.31 - $77.77 $178,868 - $197,846
2,544 Added 0.38%
668,518 $52 Billion
Q1 2021

Apr 05, 2024

BUY
$68.86 - $81.11 $1.15 Million - $1.35 Million
16,684 Added 2.57%
665,974 $51.3 Billion
Q4 2020

Apr 05, 2024

SELL
$71.77 - $79.65 $783,656 - $869,698
-10,919 Reduced 1.65%
649,290 $53.1 Billion
Q3 2020

Apr 05, 2024

BUY
$73.18 - $82.95 $11.6 Million - $13.2 Million
158,798 Added 31.67%
660,209 $54.8 Billion
Q2 2020

Apr 05, 2024

BUY
$70.42 - $80.13 $6.55 Million - $7.45 Million
92,989 Added 22.77%
501,411 $38.8 Billion
Q1 2020

Apr 05, 2024

BUY
$63.36 - $87.82 $21.8 Million - $30.2 Million
344,322 Added 537.16%
408,422 $31.4 Billion
Q4 2019

Apr 05, 2024

SELL
$77.58 - $87.54 $4.03 Million - $4.54 Million
-51,900 Reduced 44.74%
64,100 $5.83 Billion
Q3 2019

Apr 05, 2024

BUY
$76.08 - $82.93 $623,856 - $680,026
8,200 Added 7.61%
116,000 $9.76 Billion
Q2 2019

Apr 05, 2024

BUY
$69.84 - $81.59 $48,888 - $57,113
700 Added 0.65%
107,800 $9.04 Billion
Q1 2019

Apr 05, 2024

SELL
$69.58 - $79.36 $285,278 - $325,376
-4,100 Reduced 3.69%
107,100 $8.91 Billion
Q4 2018

Apr 05, 2024

SELL
$65.24 - $75.71 $1.14 Million - $1.32 Million
-17,500 Reduced 13.6%
111,200 $8.5 Billion
Q3 2018

Apr 05, 2024

BUY
$57.69 - $67.84 $2.45 Million - $2.88 Million
42,500 Added 49.3%
128,700 $9.13 Billion
Q2 2018

Apr 05, 2024

BUY
$50.83 - $59.72 $432,055 - $507,620
8,500 Added 10.94%
86,200 $5.23 Billion
Q1 2018

Apr 05, 2024

SELL
$50.96 - $59.23 $173,264 - $201,382
-3,400 Reduced 4.19%
77,700 $4.23 Billion
Q4 2017

Apr 05, 2024

SELL
$51.62 - $61.64 $15.2 Million - $18.2 Million
-294,997 Reduced 78.44%
81,100 $4.56 Billion
Q3 2017

Apr 05, 2024

BUY
$58.67 - $63.13 $2.97 Million - $3.19 Million
50,550 Added 15.53%
376,097 $24.1 Billion
Q2 2017

Apr 05, 2024

BUY
N/A
108,436 Added 49.94%
325,547 $20.9 Billion
Q1 2017

Apr 05, 2024

SELL
N/A
-3,872 Reduced 1.75%
217,111 $13.8 Billion
Q4 2016

Apr 05, 2024

BUY
N/A
4,903 Added 2.27%
220,983 $13 Billion
Q3 2016

Apr 05, 2024

BUY
N/A
11,296 Added 5.52%
216,080 $13.5 Billion
Q2 2016

Apr 05, 2024

BUY
N/A
9,200 Added 4.7%
204,784 $11.8 Billion
Q1 2016

Apr 05, 2024

BUY
N/A
46,455 Added 31.15%
195,584 $10.3 Billion
Q4 2015

Apr 05, 2024

BUY
N/A
94,929 Added 175.15%
149,129 $7.88 Billion
Q3 2015

Apr 05, 2024

SELL
N/A
-5,300 Reduced 8.91%
54,200 $2.68 Billion
Q2 2015

Apr 05, 2024

SELL
N/A
-2,100 Reduced 3.41%
59,500 $3.39 Billion
Q4 2014

Apr 05, 2024

SELL
N/A
-4,900 Reduced 7.37%
61,600 $3.55 Billion
Q1 2014

Apr 05, 2024

SELL
N/A
-5,000 Reduced 6.99%
66,500 $3.78 Billion
Q4 2013

Apr 05, 2024

SELL
N/A
-4,800 Reduced 6.29%
71,500 $3.57 Billion
Q3 2013

Apr 05, 2024

BUY
N/A
2,000 Added 2.69%
76,300 $3.63 Billion
Q2 2013

Apr 05, 2024

SELL
N/A
-9,600 Reduced 11.44%
74,300 $3.45 Billion
Q1 2013

Apr 05, 2024

BUY
N/A
4,900 Added 6.2%
83,900 $3.71 Billion
Q4 2012

Apr 05, 2024

BUY
N/A
2,500 Added 3.27%
79,000 $3.23 Billion
Q3 2012

Apr 05, 2024

BUY
N/A
1,900 Added 2.55%
76,500 $3.45 Billion
Q2 2012

Apr 05, 2024

SELL
N/A
-8,000 Reduced 9.69%
74,600 $3.11 Billion
Q1 2012

Apr 05, 2024

BUY
N/A
22,500 Added 37.44%
82,600 $3.17 Billion
Q4 2011

Apr 05, 2024

BUY
N/A
200 Added 0.33%
60,100 $2.27 Billion
Q3 2011

Apr 05, 2024

SELL
N/A
-7,800 Reduced 11.52%
59,900 $1.96 Billion
Q2 2011

Apr 05, 2024

BUY
N/A
3,400 Added 5.29%
67,700 $2.39 Billion
Q1 2011

Apr 05, 2024

BUY
N/A
12,500 Added 24.13%
64,300 $2.13 Billion
Q2 2010

Apr 05, 2024

BUY
N/A
6,100 Added 13.35%
51,800 $1.81 Billion
Q1 2010

Apr 05, 2024

BUY
N/A
2,500 Added 5.79%
45,700 $1.71 Billion
Q4 2009

Apr 05, 2024

SELL
N/A
-279,694
43,200 $1.58 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.